Welcome to the e-CCO Library!

P001: Succinate, a gut microbiota-derived metabolite, modulates the inflammatory status of the creeping fat in Crohn’s disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Serena, C.(1);Monfort-Ferre, D.(1);Bautista, M.(2);Menacho, M.(2);Martí, M.(3);Espin, E.(3);Vendrell, J.(1);Fernández-Veledo, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P001: The biomarker profile of PTG-200, an oral peptide antagonist of IL-23 receptor, tracks with efficacy in a preclinical model of IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cheng X., Taranath R., Mattheakis L., Bhandari A., Liu D.

Created: Wednesday, 20 February 2019, 10:36 AM
P002 Specific genome editing to model hypermethylation of the SP140 gene that associates to Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Hageman1, A. Li Yim2, V. Joustra3, M. Ghiboub1, K. Gecse3, A. Te Velde1, G. D’Haens3, C. Paulusma1, P. Henneman2, W. De Jonge1

Created: Thursday, 30 January 2020, 10:12 AM
P0020: Type 1 and CD103+ type 2 conventional dendritic cells are decreased in patients with active ulcerative colitis but not with Crohn’s disease.
Year: 2025
Source: ECCO'25
Authors: Bernardox7x7x7 D.(1)*;Arribas-Rodríguezx7x7x7 E.(2);G de Castrox7x7x7 C.(2);Fiz-Lópezx7x7x7 A.(2);De Pradox7x7x7 A.(2);Martín-Muñozx7x7x7 A.(3);Fernández-Salazarx7x7x7 L.(4);Barriox7x7x7 J.(5);Izquierdox7x7x7 S.(4);García-Alonsox7x7x7 F.J.(5);de Andrésx7x7x7 B.(6);García-Abrilx7x7x7 J.M.(7);Romerox7x7x7 A.(6);Sánchez-Gonzálezx7x7x7 J.(7);Arranzx7x7x7 E.(2);Chaparrox7x7x7 M.(8);Gisbertx7x7x7 J.P.(8);Garrotex7x7x7 J.A.(9);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0021: Long non-coding RNAs as predictors of response to anti-TNF therapy in Ulcerative Colitis patients
Year: 2025
Source: ECCO'25
Authors: Heydarix7x7x7 R.(1);Tavassolifarx7x7x7 M.J.(1);Derakhshan Nazarix7x7x7 M.H.(2);Shahrokhx7x7x7 S.(3);Meyfourx7x7x7 A.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0022: Development of primary human fibroblast cell cultures for fibrosis modelling in Inflammatory Bowel Diseases
Year: 2025
Source: ECCO'25
Authors: Kajárix7x7x7 L.(1x7x7x72x7x7x73)*;Szabóx7x7x7 V.(1x7x7x72x7x7x73x7x7x74);Jójártx7x7x7 B.(1x7x7x72x7x7x73x7x7x74);Bacsurx7x7x7 P.(1x7x7x75);Molnárx7x7x7 T.(1);Farkasx7x7x7 K.(1x7x7x75);Maléthx7x7x7 J.(1x7x7x72x7x7x73x7x7x74);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0023: Methionine Restriction Promotes Intestinal Mucosal Repair by Regulating Selenbp1 and Modulating Macrophage Polarization
Year: 2025
Source: ECCO'25
Authors: Wux7x7x7 L.(1);Chen x7x7x7 Y.(1);Chenx7x7x7 R.(2);Tangx7x7x7 W.(2);Liux7x7x7 Y.(3)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0024: Circadian regulator-mediated molecular subtypes depict the features of elderly ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 Y.(1)*;Xux7x7x7 J.(1);Caox7x7x7 S.(1);Wangx7x7x7 J.(1);Linx7x7x7 Y.(1);Liux7x7x7 Y.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0025: The effect of very small superparamagnetic nanoparticles on human blood cells as a diagnostic tool in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Husseinx7x7x7 S.(1x7x7x72)*;Kühlx7x7x7 A.A.(2);Golusdax7x7x7 L.(1x7x7x72);Plattnerx7x7x7 C.(3);Heinzex7x7x7 N.(1x7x7x72);Sturmx7x7x7 G.(3);Freise x7x7x7 C.(4);Traubex7x7x7 H.(5);Trajanoskix7x7x7 Z.(3);Taupitzx7x7x7 M.(5);Schnorrx7x7x7 J.(4);Siegmundx7x7x7 B.(1);Paclikx7x7x7 D.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0026: Multi-omics phenotyping characterizes perturbed molecular divergence underlying different clinical scenarios of under-treatment inflammatory bowel disease
Year: 2025
Source: ECCO'25
Authors: Leex7x7x7 H.S.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0027: The carbon footprint of remote monitoring of IBD patients – a green opportunity for sustainable outpatient care
Year: 2025
Source: ECCO'25
Authors: Hendrix x7x7x7 E.M.B.(1x7x7x72);de Jong x7x7x7 D.C.(3);de Jong x7x7x7 M.J.(4);Becx x7x7x7 M.C.J.M.(5);van Bodegraven x7x7x7 A.A.(6);Dijkstra x7x7x7 G.(7);Kimman x7x7x7 M.(8x7x7x79);Mahmmod x7x7x7 N.(5);Maljaars x7x7x7 J.P.(10);van der Meulen-de Jong x7x7x7 A.E.(10);Mujagic x7x7x7 Z.(1x7x7x72);Romberg-Camps x7x7x7 M.J.(6);Pierik x7x7x7 M.J.(1x7x7x72)*;Duijvestein x7x7x7 M.(11);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0028: Discovery of GLP-2R agonists using computational molecular design techniques
Year: 2025
Source: ECCO'25
Authors: Scagnolix7x7x7 B.(1);Righinox7x7x7 B.(1);Pirollix7x7x7 D.(1);Lopetusox7x7x7 L.(2);Chieppax7x7x7 M.(3);Moccix7x7x7 G.(4);Petitox7x7x7 V.(5);Scaldaferrix7x7x7 F.(6x7x7x77)*;Gasbarrinix7x7x7 A.(7x7x7x78);Papax7x7x7 A.(7x7x7x79);De Rosax7x7x7 M.C.(10);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0029: Abnormal glycerophospholipid metabolism in CCL2+DPP4+ mesenchymal stem cells may contributes to creeping fat fibrosis in Crohn's Disease
Year: 2025
Source: ECCO'25
Authors: Yux7x7x7 A.(1)*;Wux7x7x7 F.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P002: Beneficial effects of blocking EphBs-ephrinBs forward signalling in a murine Crohn’s sisease (CD) model
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Grandi, I. Zini, M. Tognolini, V. Ballabeni, E. Barocelli, S. Bertoni*

Created: Friday, 22 February 2019, 9:49 AM
P002: Endoscopic placement of a drug-eluting platform with monoclonal antibodies in an animal model of experimental colitis by TNBS: effect on disease outcome and anti-drug antibodies (ADA’s) formation
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Bon-Romero1,2, R. Bartolí1,2,3, N. De la Ossa4, V. Moreno de Vega2, I. Marín2, E. Domènech1,2,3, V. Lorenzo-Zúñiga1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P002: Epithelial to mesenchymal transition is a hallmark of fibrostenosing Crohn’s disease and is associated with down regulation of the miR-200 family
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.J. Mehta1*, A. Lewis1, A. Nijhuis1, R. Jeffery1, R. Feakins1,2, A. Silver1, J.O. Lindsay1,3

Created: Thursday, 21 February 2019, 9:14 AM
P002: Exclusive Enteral Nutrition, the gut microbiome and corticosteroid response in patients with acute severe colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bajaj, A.(1)*;Markandey, M.(1);Vuyyuru, S.(1);Mohta, S.(1);Singh, M.(1);Verma, M.(1);Kumar, S.(1);Kante, B.(1);Kumar, P.(1);Makharia, G.(1);Kedia, S.(1);Travis, S.(2);Ahuja, V.(1);
Created: Friday, 14 July 2023, 10:43 AM
P002: Glial cell line-Derived Neurotrophic Factor (GDNF) improves intestinal wound healing – A new target for IBD treatment?
Year: 2022
Source: ECCO'22
Authors: Kelm, M.(1);Burkard, N.(1);Hoerner, M.(1);Germer, C.T.(1);Schlegel, N.(1);Flemming, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P002: Inhibition of Axl signaling by BGB324 reduces fibrogenesis in human intestinal cells and human intestinal organoids
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Steiner C.1, Rodansky E.2, Johnson L.A.2, Huang S.2, Spence J.1, Higgins P.D.*3

Created: Wednesday, 20 February 2019, 10:36 AM
P002: Methodological development of single-cell phenotyping and spatial analysis of intestinal leukocyte, stromal and epithelial cell populations in inflammatory bowel disease formalin fixed paraffin embedded tissue by Hyperion imaging mass cytometry
Year: 2021
Source: ECCO'21 Virtual
Authors: Lamb, C.A.(1,2);Doyle, J.(1);Hulme, G.(3);Cooke, K.(1);Au-Yeung, A.(4);Ojeda-Garcia, J.(3);Fuller, A.(3);McDonald, D.(3);Mansfield, J.C.(1,2);Kirby, J.A.(1);McBride, J.(4);Speight, R.A.(1,2);O’Gorman, W.(4);Filby, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM